Shopping Cart
- Remove All
- Your shopping cart is currently empty
ABT530 (Pibrentasvir) is an HCV NS5A inhibitor with EC50s ranging from 1.4-5.0 pM against HCV replicons containing NS5A from genotypes 1-6.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | $40 | In Stock | |
25 mg | $81 | In Stock | |
50 mg | $129 | In Stock | |
100 mg | $198 | In Stock | |
1 mL x 10 mM (in DMSO) | $48 | In Stock |
Description | ABT530 (Pibrentasvir) is an HCV NS5A inhibitor with EC50s ranging from 1.4-5.0 pM against HCV replicons containing NS5A from genotypes 1-6. |
Targets&IC50 | HCV NS5A:1.4-5.0 pM(EC50) |
Alias | Pibrentasvir, ABT-530, ABT 530 |
Molecular Weight | 1113.18 |
Formula | C57H65F5N10O8 |
Cas No. | 1353900-92-1 |
Smiles | CO[C@H](C)[C@H](NC(=O)OC)C(=O)N1CCC[C@H]1c1nc2cc(F)c(cc2[nH]1)[C@H]1CC[C@@H](N1c1cc(F)c(N2CCC(CC2)c2ccc(F)cc2)c(F)c1)c1cc2[nH]c(nc2cc1F)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)OC)[C@@H](C)OC |
Relative Density. | 1.363 g/cm3 (Predicted) |
Storage | keep away from direct sunlight,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | DMSO: 50 mg/mL (44.92 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.